PlainRecalls
FDA Drug Critical Class I Terminated

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Reported: February 1, 2023 Initiated: December 6, 2022 #D-0182-2023

Product Description

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Reason for Recall

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Details

Units Affected
88,380 capsules
Distribution
Nationwide in the USA.
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3. Recalled by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon. Units affected: 88,380 capsules.
Why was this product recalled?
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2023. Severity: Critical. Recall number: D-0182-2023.